These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
738 related articles for article (PubMed ID: 18937970)
1. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma. Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970 [TBL] [Abstract][Full Text] [Related]
2. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer. Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815 [TBL] [Abstract][Full Text] [Related]
3. Is there a prognostic difference between depth of myometrial invasion and the tumor-free distance from the uterine serosa in endometrial cancer? Lindauer J; Fowler JM; Manolitsas TP; Copeland LJ; Eaton LA; Ramirez NC; Cohn DE Gynecol Oncol; 2003 Dec; 91(3):547-51. PubMed ID: 14675674 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer. Kondalsamy-Chennakesavan S; van Vugt S; Sanday K; Nicklin J; Land R; Perrin L; Crandon A; Obermair A Int J Gynecol Cancer; 2010 Oct; 20(7):1217-21. PubMed ID: 21495232 [TBL] [Abstract][Full Text] [Related]
5. Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50%. Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Massuger LF Gynecol Oncol; 2013 May; 129(2):285-91. PubMed ID: 23422503 [TBL] [Abstract][Full Text] [Related]
6. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691 [TBL] [Abstract][Full Text] [Related]
7. Predictors of final histology in patients with endometrial cancer. Frumovitz M; Singh DK; Meyer L; Smith DH; Wertheim I; Resnik E; Bodurka DC Gynecol Oncol; 2004 Dec; 95(3):463-8. PubMed ID: 15581947 [TBL] [Abstract][Full Text] [Related]
8. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma. Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832 [TBL] [Abstract][Full Text] [Related]
9. Significance of lower uterine segment involvement in women with stage I endometrial adenocarcinoma. Gemer O; Uriev L; Harkovsky T; Peled R; Ben-Dor D; Barak F; Segal S J Reprod Med; 2004 Sep; 49(9):703-6. PubMed ID: 15493559 [TBL] [Abstract][Full Text] [Related]
10. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441 [TBL] [Abstract][Full Text] [Related]
11. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400 [TBL] [Abstract][Full Text] [Related]
12. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study. Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311 [TBL] [Abstract][Full Text] [Related]
13. [Multivariate analysis of prognostic factors in endometrial carcinoma]. Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208 [TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of lower uterine segment involvement in surgically staged endometrial cancer patients with negative nodes. Brown AK; Madom L; Moore R; Granai CO; DiSilvestro P Gynecol Oncol; 2007 Apr; 105(1):55-8. PubMed ID: 17157904 [TBL] [Abstract][Full Text] [Related]
15. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement. Boren T; Lea J; Kehoe S; Miller DS; Richardson D Gynecol Oncol; 2012 Oct; 127(1):43-6. PubMed ID: 22713294 [TBL] [Abstract][Full Text] [Related]
16. Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium. Desrosiers L; Fadare O; Xiao ZF; Dresser K; Wang SA Ann Diagn Pathol; 2008 Apr; 12(2):112-7. PubMed ID: 18325471 [TBL] [Abstract][Full Text] [Related]
17. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. Frumovitz M; Slomovitz BM; Singh DK; Broaddus RR; Abrams J; Sun CC; Bevers M; Bodurka DC J Am Coll Surg; 2004 Sep; 199(3):388-93. PubMed ID: 15325608 [TBL] [Abstract][Full Text] [Related]
18. Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome. Gayar OH; Robbins JR; Parikh K; Lu M; Buekers T; Munkarah A; Elshaikh MA Gynecol Oncol; 2011 Oct; 123(1):71-5. PubMed ID: 21767871 [TBL] [Abstract][Full Text] [Related]